Jinkui Shenqi Wan alleviates doxorubicin-induced renal senescence and injury: insights from network pharmacology and serum UHPLC-MS/MS

Background Renal cellular senescence drives progressive fibrosis and raises the risk of end-stage renal disease in chronic kidney disease (CKD). Jinkui Shenqi Wan (JKSQW) is a classical eight-herb Chinese formula with a long history of use in tonifying kidney essence and delaying aging. However, the core anti-senescent components and key mechanisms of Jinkui Shenqi Wan remain unclear. Methods To evaluate JKSQW in vivo , we established a doxorubicin-induced senescence mouse model and assessed renal function, histopathology, and senescence markers (serum creatinine, BUN, proteinuria, urinary RBCs, SA-β-gal, p16/p21). Active components were screened from TCMSP (OB ≥ 30%, DL ≥ 0.18) and intersected with CKD- and aging-related targets from GeneCards and OMIM. UHPLC-MS/MS profiled JKSQW and identified blood-absorbed prototypes; their targets underwent GO/KEGG enrichment. Molecular docking assessed oxypaeoniflorin binding to 13 core PPI targets. Exosome-like nanoparticles from Moutan Cortex (MDP-Exo) were isolated and evaluated in doxorubicin-treated podocytes using SA-β-gal staining and p16/p21 expression analysis. Results In vivo , JKSQW reduced serum creatinine, blood urea nitrogen, proteinuria, and urinary red blood cell counts, alleviated renal pathological injury, decreased SA-β-gal-positive area, and downregulated p16 and p21. Network pharmacology using TCMSP identified 102 active ingredients and 206 targets; intersection with CKD- and aging-related targets yielded 48 overlapping genes, and PPI analysis identified 13 core targets, including AKT1, TNF, PTGS2, MMP9, and TP53. UHPLC-MS/MS identified 1,452 compounds in JKSQW, including 277 blood-absorbed prototypes. Their 980 unique targets were intersected with disease targets, yielding 349 overlapping targets; KEGG enrichment indicated pathways related to cell-cycle regulation, oxidative stress, and fibrosis. Molecular docking showed that oxypaeoniflorin, a characteristic blood-absorbed monoterpene glycoside from Moutan Cortex, bound 12 of 13 core targets, with 8 showing strong binding. Since Moutan Cortex contributed the most predicted targets and oxypaeoniflorin showed broad binding, we isolated MDP-Exo, which attenuated doxorubicin-induced podocyte senescence and downregulated p16 and p21 in vitro . Conclusion Collectively, these findings demonstrate that JKSQW alleviates doxorubicin-induced renal senescence and injury. Through integrated network pharmacology and serum UHPLC-MS/MS, we identified the blood-absorbed components and their predicted pathways, with oxypaeoniflorin from Moutan Cortex exhibiting broad binding to core targets and MDP-Exo attenuating podocyte senescence.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-18
DOI
https://doi.org/10.3389/fcell.2026.2010658
Primary Topic
Traditional Chinese Medicine Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Jinkui Shenqi Wan alleviates doxorubicin-induced renal senescence and injury: insights from network pharmacology and serum UHPLC-MS/MS

Shan Zhang, Rong Zou, Chen Sun, Baihui Wang et al.
4 links
Frontiers in Cell and Developmental Biology
Traditional Chinese Medicine Analysis
article

Jinkui Shenqi Wan alleviates doxorubicin-induced renal senescence and injury: insights from network pharmacology and serum UHPLC-MS/MS

Shan Zhang, Rong Zou, Chen Sun, Baihui Wang, Limin Tian
article en

Abstract

Background Renal cellular senescence drives progressive fibrosis and raises the risk of end-stage renal disease in chronic kidney disease (CKD). Jinkui Shenqi Wan (JKSQW) is a classical eight-herb Chinese formula with a long history of use in tonifying kidney essence and delaying aging. However, the core anti-senescent components and key mechanisms of Jinkui Shenqi Wan remain unclear. Methods To evaluate JKSQW in vivo , we established a doxorubicin-induced senescence mouse model and assessed renal function, histopathology, and senescence markers (serum creatinine, BUN, proteinuria, urinary RBCs, SA-β-gal, p16/p21). Active components were screened from TCMSP (OB ≥ 30%, DL ≥ 0.18) and intersected with CKD- and aging-related targets from GeneCards and OMIM. UHPLC-MS/MS profiled JKSQW and identified blood-absorbed prototypes; their targets underwent GO/KEGG enrichment. Molecular docking assessed oxypaeoniflorin binding to 13 core PPI targets. Exosome-like nanoparticles from Moutan Cortex (MDP-Exo) were isolated and evaluated in doxorubicin-treated podocytes using SA-β-gal staining and p16/p21 expression analysis. Results In vivo , JKSQW reduced serum creatinine, blood urea nitrogen, proteinuria, and urinary red blood cell counts, alleviated renal pathological injury, decreased SA-β-gal-positive area, and downregulated p16 and p21. Network pharmacology using TCMSP identified 102 active ingredients and 206 targets; intersection with CKD- and aging-related targets yielded 48 overlapping genes, and PPI analysis identified 13 core targets, including AKT1, TNF, PTGS2, MMP9, and TP53. UHPLC-MS/MS identified 1,452 compounds in JKSQW, including 277 blood-absorbed prototypes. Their 980 unique targets were intersected with disease targets, yielding 349 overlapping targets; KEGG enrichment indicated pathways related to cell-cycle regulation, oxidative stress, and fibrosis. Molecular docking showed that oxypaeoniflorin, a characteristic blood-absorbed monoterpene glycoside from Moutan Cortex, bound 12 of 13 core targets, with 8 showing strong binding. Since Moutan Cortex contributed the most predicted targets and oxypaeoniflorin showed broad binding, we isolated MDP-Exo, which attenuated doxorubicin-induced podocyte senescence and downregulated p16 and p21 in vitro . Conclusion Collectively, these findings demonstrate that JKSQW alleviates doxorubicin-induced renal senescence and injury. Through integrated network pharmacology and serum UHPLC-MS/MS, we identified the blood-absorbed components and their predicted pathways, with oxypaeoniflorin from Moutan Cortex exhibiting broad binding to core targets and MDP-Exo attenuating podocyte senescence.

Frontiers in Cell and Developmental BiologyVol. 14
Hubei University of Chinese Medicine (CN), Third Affiliated Hospital of Guangzhou Medical University (CN), Integrated Chinese Medicine (China) (HK), Community Health Center (US), Hubei Provincial Hospital of Integrative Medicine (CN), Huazhong University of Science and Technology (CN), Guangzhou Medical University (CN)
Good health and well-being
Traditional Chinese Medicine Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon